|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MOLDFLOW CORP, 10-Q, 2000-11-07 |
Next: INTRABIOTICS PHARMACEUTICALS INC /DE, 10-Q, 2000-11-07 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 19,909
<SECURITIES> 13,846
<RECEIVABLES> 6,132
<ALLOWANCES> (436)
<INVENTORY> 222
<CURRENT-ASSETS> 41,430
<PP&E> 9,358
<DEPRECIATION> (4,088)
<TOTAL-ASSETS> 55,508
<CURRENT-LIABILITIES> 11,622
<BONDS> 840
0
0
<COMMON> 93
<OTHER-SE> 42,914
<TOTAL-LIABILITY-AND-EQUITY> 55,508
<SALES> 5,222
<TOTAL-REVENUES> 8,824
<CGS> 341
<TOTAL-COSTS> 684
<OTHER-EXPENSES> 7,630
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 22
<INCOME-PRETAX> 917
<INCOME-TAX> 383
<INCOME-CONTINUING> 534
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 534
<EPS-BASIC> 0.06
<EPS-DILUTED> 0.06
</TABLE>
|
|